<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about MR</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Wed, 19 Jun 2013 07:24:51 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=MR" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/mindray-to-takeover-zonare-analyst-blog-cm253698">
      <guid isPermaLink="false">253698</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TWWMpDMDzz4/mindray-to-takeover-zonare-analyst-blog-cm253698</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Mindray to Takeover ZONARE - Analyst Blog</title>
      <description>Chinese medical devices major  Mindray Medical International Limited  (  MR  ) recently reported a definitive agreement to takeover ZONARE Medical Systems, Inc. (ZONARE), for $105 million.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/TWWMpDMDzz4" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 17 Jun 2013 22:30:08 Z</pubDate>
      <a10:updated>2013-06-17T19:33:02Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-to-takeover-zonare-analyst-blog-cm253698</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205">
      <guid isPermaLink="false">244205</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JckKtUlbiVA/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Mindray Beats Earnings Est, Misses Rev - Analyst Blog</title>
      <description>Chinese medical devices major,  Mindray Medical  International Limited  (  MR  ) reported  first-quarter 2013 adjusted (excluding one-time expenses other than  stock-based compensation expense)&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JckKtUlbiVA" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 17:31:56 Z</pubDate>
      <a10:updated>2013-05-07T13:32:11Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078">
      <guid isPermaLink="false">244078</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3qVl3vRE6A/holx-beats-earnings-view-slashed-analyst-blog-cm244078</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>HOLX Beats Earnings, View Slashed - Analyst Blog</title>
      <description>Hologic Inc.  (  HOLX  ) reported  adjusted earnings per share of 35 cents in the second quarter of  fiscal 2013, higher than the year-ago earnings of 33 cents as well  as the company's&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/R3qVl3vRE6A" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 16:24:13 Z</pubDate>
      <a10:updated>2013-05-07T12:24:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072">
      <guid isPermaLink="false">244072</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BmjHug8F7Bc/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Volcano Beats Earnings, Downturn Ahead - Analyst Blog</title>
      <description>Volcano Corporation  (  VOLC  ) reported adjusted earnings per share (EPS) of 2 cents in the first quarter of 2013. The result betters the year-ago break-even level as well as the Zacks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/BmjHug8F7Bc" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 16:23:01 Z</pubDate>
      <a10:updated>2013-05-07T13:36:19Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>PCI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916">
      <guid isPermaLink="false">243916</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/siqlDExP3FE/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>After-Hours Earnings Report for May 6, 2013 :  APC, PAA, VNO, HOLX, MELI, FTR, FSLR, MR, PRA, PL, DPM, SMG</title>
      <description>The following companies are expected to report earnings after hours on 05/06/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Anadarko Petroleum Corporation  (&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/siqlDExP3FE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 22:00:04 Z</pubDate>
      <a10:updated>2013-05-06T18:22:14Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>APC</nasdaq:tickers>
      <nasdaq:tickers>DPM</nasdaq:tickers>
      <nasdaq:tickers>FSLR</nasdaq:tickers>
      <nasdaq:tickers>FTR</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MELI</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>PAA</nasdaq:tickers>
      <nasdaq:tickers>PL</nasdaq:tickers>
      <nasdaq:tickers>PRA</nasdaq:tickers>
      <nasdaq:tickers>SMG</nasdaq:tickers>
      <nasdaq:tickers>VNO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/afterhours-earnings-report-for-may-6-2013-apc-paa-vno-holx-meli-ftr-fslr-mr-pra-pl-dpm-smg-cm243916</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/dismal-earnings-miss-by-omnicell-analyst-blog-cm243346">
      <guid isPermaLink="false">243346</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sTW9W3AVTns/dismal-earnings-miss-by-omnicell-analyst-blog-cm243346</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Dismal Earnings Miss by Omnicell - Analyst Blog</title>
      <description>Omnicell Inc.  (  OMCL  ) reported first-quarter 2013 net operating earnings of 14 cents per share, missing the Zacks Consensus Estimate of 19 cents. Results nevertheless improved 7.7% year&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sTW9W3AVTns" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 16:33:07 Z</pubDate>
      <a10:updated>2013-05-03T13:35:24Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>OMCL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/dismal-earnings-miss-by-omnicell-analyst-blog-cm243346</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850">
      <guid isPermaLink="false">237850</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C8y828msscw/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>More Backing for HOLX Tomosynthesis - Analyst Blog</title>
      <description>Leading player in the women's health market  Hologic Inc.  (  HOLX  ) continues to leap forward with positive data supporting the adoption of its tomosynthesis technology. The company stated&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/C8y828msscw" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 17 Apr 2013 23:10:39 Z</pubDate>
      <a10:updated>2013-04-17T20:15:57Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/more-backing-for-holx-tomosynthesis-analyst-blog-cm237850</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mindray-to-exhibit-at-cmef-analyst-blog-cm233766">
      <guid isPermaLink="false">233766</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HuNFqny3rkM/mindray-to-exhibit-at-cmef-analyst-blog-cm233766</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Mindray to Exhibit at CMEF - Analyst Blog</title>
      <description>Chinese medical devices major  Mindray Medical International Limited  (  MR  ) recently revealed that it will showcase over 60 offerings at the 69th China International Medical Equipment Fair&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/HuNFqny3rkM" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 04 Apr 2013 22:06:02 Z</pubDate>
      <a10:updated>2013-04-04T19:11:03Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-to-exhibit-at-cmef-analyst-blog-cm233766</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/fda-panel-favors-abbotts-mitraclip-analyst-blog-cm230658">
      <guid isPermaLink="false">230658</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vw07QKaQnbY/fda-panel-favors-abbotts-mitraclip-analyst-blog-cm230658</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>FDA Panel Favors Abbott's MitraClip - Analyst Blog</title>
      <description>Abbott Laboratories  (  ABT  ) recently announced that the US Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted in favor&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Vw07QKaQnbY" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Mar 2013 02:26:53 Z</pubDate>
      <a10:updated>2013-03-25T23:29:06Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>ABV</nasdaq:tickers>
      <nasdaq:tickers>FURX</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>NVO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/fda-panel-favors-abbotts-mitraclip-analyst-blog-cm230658</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/abiomed-remains-neutral-analyst-blog-cm230015">
      <guid isPermaLink="false">230015</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z_M9z-Q8Ms4/abiomed-remains-neutral-analyst-blog-cm230015</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Abiomed Remains Neutral - Analyst Blog</title>
      <description>On Mar 21, we retained  Abiomed Inc.  (  ABMD  ) at Neutral following its impressive third-quarter fiscal 2013 results. Although its earnings managed to beat estimates, we remain on the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/z_M9z-Q8Ms4" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 23 Mar 2013 03:25:11 Z</pubDate>
      <a10:updated>2013-03-23T00:25:22Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/abiomed-remains-neutral-analyst-blog-cm230015</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/data-on-abbotts-mitraclip-analyst-blog-cm227670">
      <guid isPermaLink="false">227670</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0LQ5i7mfHw0/data-on-abbotts-mitraclip-analyst-blog-cm227670</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Data on Abbott's MitraClip  - Analyst Blog</title>
      <description>Abbott  (  ABT  ) recently released positive data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort.  The study evaluated Abbott's MitraClip system&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/0LQ5i7mfHw0" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 15 Mar 2013 20:46:30 Z</pubDate>
      <a10:updated>2013-03-15T17:49:00Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>LLY</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>NVO</nasdaq:tickers>
      <nasdaq:tickers>SHPG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/data-on-abbotts-mitraclip-analyst-blog-cm227670</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/reiterate-mindray-at-neutral-analyst-blog-cm226859">
      <guid isPermaLink="false">226859</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zvD4cNViUtw/reiterate-mindray-at-neutral-analyst-blog-cm226859</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Reiterate Mindray at Neutral - Analyst Blog</title>
      <description>On Mar 8, 2013, we retained  Mindray Medical International Limited  (  MR  ) at Neutral after the company beat Zacks Consensus Estimates for earnings and revenue for fourth quarter 2012.   Why&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/zvD4cNViUtw" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 13 Mar 2013 23:12:16 Z</pubDate>
      <a10:updated>2013-03-13T20:14:30Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/reiterate-mindray-at-neutral-analyst-blog-cm226859</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mindray-medical-international-limited-mr-exdividend-date-scheduled-for-march-06-2013-cm222916">
      <guid isPermaLink="false">222916</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0HoubiW1eYg/mindray-medical-international-limited-mr-exdividend-date-scheduled-for-march-06-2013-cm222916</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Mindray Medical International Limited (MR) Ex-Dividend Date Scheduled for March 06, 2013</title>
      <description>Mindray Medical International Limited (  MR  ) will begin trading ex-dividend on March 06, 2013. A cash dividend payment of $0.5 per share is scheduled to be paid on April 12, 2013. Shareholders&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/0HoubiW1eYg" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 04 Mar 2013 19:00:03 Z</pubDate>
      <a10:updated>2013-03-04T14:29:50Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BAX</nasdaq:tickers>
      <nasdaq:tickers>HGEM</nasdaq:tickers>
      <nasdaq:tickers>MMM</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-medical-international-limited-mr-exdividend-date-scheduled-for-march-06-2013-cm222916</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mindray-beats-in-4q-profit-up-analyst-blog-cm221199">
      <guid isPermaLink="false">221199</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6aBFXMwXLes/mindray-beats-in-4q-profit-up-analyst-blog-cm221199</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Mindray Beats in 4Q, Profit Up - Analyst Blog</title>
      <description>Chinese medical devices major  Mindray Medical International Limited  's (  MR  ) fourth-quarter 2012 adjusted (excluding one-time expenses other than stock-based compensation expense) earnings&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/6aBFXMwXLes" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Feb 2013 18:30:01 Z</pubDate>
      <a10:updated>2013-02-26T15:34:45Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>GIVN</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>NVDQ</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-beats-in-4q-profit-up-analyst-blog-cm221199</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/afterhours-earnings-report-for-february-25-2013-hcn-oke-oks-adsk-meli-oas-urs-mr-chmt-sf-lgcy-czr-cm220879">
      <guid isPermaLink="false">220879</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/auwCUSHMIJY/afterhours-earnings-report-for-february-25-2013-hcn-oke-oks-adsk-meli-oas-urs-mr-chmt-sf-lgcy-czr-cm220879</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>After-Hours Earnings Report for February 25, 2013 :  HCN, OKE, OKS, ADSK, MELI, OAS, URS, MR, CHMT, SF, LGCY, CZR</title>
      <description>The following companies are expected to report earnings after hours on 02/25/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Health Care REIT, Inc.  (  HCN  )&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/auwCUSHMIJY" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Feb 2013 00:00:04 Z</pubDate>
      <a10:updated>2013-02-25T19:17:19Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>ADSK</nasdaq:tickers>
      <nasdaq:tickers>CHMT</nasdaq:tickers>
      <nasdaq:tickers>CZR</nasdaq:tickers>
      <nasdaq:tickers>HCN</nasdaq:tickers>
      <nasdaq:tickers>LGCY</nasdaq:tickers>
      <nasdaq:tickers>MELI</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>OAS</nasdaq:tickers>
      <nasdaq:tickers>OKE</nasdaq:tickers>
      <nasdaq:tickers>OKS</nasdaq:tickers>
      <nasdaq:tickers>SF</nasdaq:tickers>
      <nasdaq:tickers>URS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/afterhours-earnings-report-for-february-25-2013-hcn-oke-oks-adsk-meli-oas-urs-mr-chmt-sf-lgcy-czr-cm220879</feedburner:origLink></item>
  </channel>
</rss>
